Hypothyroidism stimulates D 2 receptor-mediated breathing in response to acute hypoxia and alters D 2 receptors levels in carotid bodies and brain

Respiratory Physiology and Neurobiology

Volumn 180, Issue 1, 2012, Pages 69-78

  Schlenker, Evelyn H ^a   Schultz, Harold D ^b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Dopamine D 2 receptors; Hypothyroidism; Hypoxia; Ventilation

Indexed keywords

BROMOCRIPTINE; CARMOXIROLE; DOPAMINE 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; BREATHING; CAROTID BODY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHYROIDISM; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SYRIAN HAMSTER; TISSUE LEVEL; ANIMAL; ANOXIA; BIOSYNTHESIS; BRAIN; DISEASE MODEL; HAMSTER; METABOLISM; PATHOPHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; ANOXIA; BLOTTING, WESTERN; BRAIN; CAROTID BODY; CRICETINAE; DISEASE MODELS, ANIMAL; HYPOTHYROIDISM; MALE; MESOCRICETUS; RECEPTORS, DOPAMINE D2; RESPIRATION;

EID: 83555176325     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2011.10.013     Document Type: Article

References (57)

1. Ángyán L., Ángyán Z. Characterization of cardiorespiratory responses to electricalstimulation of the globuspallidus in cat. Physiol. Behav. 1999, 66:53-58.
2. Aoki Y., Berlin R.M., Clickner R., Jeffries R., Phillips L., Mahaffey K. Serum TSH and total T4 in the United States population and their association with participant charactersitics: national health and nutrion examination survey (NHANES 1999-2002). Thyroid 2007, 12:1211-1223.
3. Atsumi M., Kawakami J., Sugiyama E., Kotaki H., Sawada Y., Sato H., Yamada Y., Iga T. Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2 receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats. Synapse 2003, 50:110-116.
4. Bairam A., Hannhart B., Chon C., Marchal F. Effects of dopamine on the carotid chemosensory response to hypoxia in newborn kittens. Respir. Physiol. 1993, 94:297-307.
5. Bascom D.A., Clement I.D., Dorrington K.L., Robbins P.A. Effects of dopamine and domperidone on ventilation during isocapnic hypoxia in humans. Respir. Physiol. 1991, 85:319-328.
6. Beaulieu J.-M., Gainetdinov R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 2011, 63:182-217.
7. Burton M.D., Kazemi H. Neurotransmitters in central respiratory control. Respir. Physiol. 2000, 122:111-121.
8. Cameron D.L., Crocker A.D. Post-synaptic changes and increased dopamine receptor sensitivity in hypothyroid rats. Pharmacol. Biochem. Behav. 1987, 28:193.
9. Cameron D.L., Crocker A.D. The hypothyroid rat as a model of increased sensitivity to dopamine receptor agonists. Pharmacol. Biochem. Behav. 1990, 37:627-632.
10. Crocker A.D., Cameron D.L. Evidence of post-synaptic changes mediating increased behavioral sensitivity to dopamine receptor agonists in hypothyroid rats. Prog. Neuropsycopharmacol. Biol. Psychiatry 1988, 12:607-615.
11. Crocker A.D., Overstreet D., Crocker J.M. Hypothyroism leads to increased dopamine receptor sensitivity and concentration. Pharmacol. Biochem. Behav. 1986, 24:1593-1597.
12. DeFronzo R.A. Bromocriptine: a sympatholytic, D2-dopamine agonist for the treatment of Type 2 Diabetes. Diabetes Care 2011, 34:789-794.
13. Diez D., Grijota-Martinez C., Agretti P., De Marco G., Tonacchera M., Pinchera A., de Escobar G.M., Bernal J., Morte B. Thyroid hormone action in the adult brain: gene expression profiling of the effects of single and multiple doses of triiodo-l-thyronine in the rat striatum. Endocrinology 2008, 2008-2350.
14. Duntas L., Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk. Semin. Thromb. Hemost. 2011, 37:27-34.
15. Economidou F., Douka E., Tzanela M., Nanas S., Kotanidou A. Thyroid function during critical illness. Hormones 2011, 10:117-124.
16. Evans K.C., Shea S.A., Saykin A.J. Functional MRI localisation of central nervous system regions associated with volitional inspiration in humans. J. Physiol. 1999, 520:383-392.
17. Fagerlund M., Khlin J., Ebberyd A., Schulte G., Mkrtchian S., Eriksson L. The human carotid body: expression of oxygen sensing and signaling genes of relevance for anesthesia. Anesthesiology 2010, 113:1270-1279.
18. Genest S.-E., Balon N., Laforest S., Drolet G., Kinkead R. Neonatal maternal separation and enhancement of the hypoxic ventilatory response in rat: the role of GABAergic modulation within the paraventricular nucleus of the hypothalamus. J. Physiol. 2007, 583:299-314.
19. Gong J., Liu W., Dong J., Wang Y., Xu H., Wei W., Zhong J., Xi Q., Chen J. Developmental iodine deficiency and hypothyroidism impair neural development in rat hippocampus: involvement of doublecortin and NCAM-180. BMC Neurosci. 2010, 11:50.
20. Granjeiro É.M., Machado B.H. NO in the caudal NTS modulates the increase in respiratory frequency in response to chemoreflex activation in awake rats. Respir. Physiol. Neurobiol. 2009, 166:32-40.
21. Guner I., Yelmen N., Sahin G., Oruc T. The effect of intracerebroventricular dopamine administration on the respiratory response to hypoxia. Tohoku J. Exp. Med. 2002, 196:219-230.
22. Haase A.F., Greiner H.E., Seyfried C.A. Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist. Naunyn-Schmiedeberg's Arch. Pharmacol. 1991, 343:588-594.
23. Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., Braverman L.E. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 2002, 87:489-499.
24. Huey K.A., Szewczak J.M., Powell F.L. Dopaminergic mechanisms of neural plasticity in respiratory control: transgenic approaches. Respir. Physiol. Neurobiol. 2003, 135:133-144.
25. Jha A., Sharma S.K., Tandon N., Lakshmy R., Kadhiravan T., Handa K.K., Gupta R., Pandey R.M., Chaturvedi P.K. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism. Sleep Med. 2006, 7:55-66.
26. Kline D.D., Takacs K.N., Ficker E., Kunze D.L. Dopamine modulates synaptic transmission in the nucleus of the solitary tract. J. Neurophysiol. 2002, 88:2736-2744.
27. Kulikov A.V., Zubkov E.A. Chronic thyroxine treatment activates the 5-HT2A serotonin receptor in the mouse brain. Neurosci. Lett. 2007, 416:307-309.
28. Marchese G., Ruiu S., Casti P., Bartholini F., Saba P., Gessa G.L., Pani L. Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect. Eur. J. Pharmacol. 2002, 447:109-114.
29. McKay L.C., Evans K.C., Frackowiak R.S.J., Corfield D.R. Neural correlates of voluntary breathing in humans. J. Appl. Physiol. 2003, 95:1170-1178.
30. Meyer S., Schuetz P., Wieland M., Nusbaumer C., Mueller B., Christ Crain M. Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis?. Endocrine 2011, 39:167-174.
31. Misiolek M., Marek B., Namyslowski G., Scierski W., Zwirska-Korczala K., Kazmierczak-Zagorska Z., Kajdaniuk D., Misiolek H. Sleep apnea syndrome and snoring in patients with hypothyroidism with relation to overweight. J. Physiol. Pharmacol. 2007, 58(Suppl. 1):77-85.
32. Morin L.P., Wood R.I. A Stereotaxic Atlas of the Golden Hamster Brain 2001, Academic Press, Harcourt Science and Technology Co, San Diego CA.
33. Mustafa A. Bromocriptine-induced hypothermia in Balb/C mice: its possible mechanism of action. Gen. Pharmacol. 1991, 22:545-548.
34. Nielsen A.M., Bisgard G.E. Differential effects on phrenic output of two dopamine agonists, apomorphine and bromocriptine. Eur. J. Pharmacol. 1984, 106:69-78.
35. O'Halloran K.D., Janssen P.L., Bisgard G.E. Dopaminergic modulation of respiratory motor output in peripherally chemodenervated goats. J. Appl. Physiol. 1998, 85:946-954.
36. Oh-Nishi A., Saji M., Furudate S.I., Suzuki N. Dopamine D2-like receptor function is converted from excitatory to inhibitory by thyroxine in the developmental hippocampus. J. Neuroendonol. 2005, 17:836-845.
37. Olea E., Gonzalez C., Gallego R., Geijo-Barrientos E.L.A. PTU-induced hypothyroidism reduces hypoxic ventilatory drive by impairing carotid body chemsensitivity in adult rats. Acta Physiol. 2007, 190(Suppl. 655):P51.
38. Orset C., Parrot S., Sauvinet V., Cottet-Emard J.-M., Berod A., Pequignot J.-M., Denoroy L. Dopamine transporters are involved in the onset of hypoxia-induced dopamine efflux in striatum as revealed by in vivo microdialysis. Neurochem. Int. 2005, 46:623-633.
39. Pedersen M.E.F., Dorrington K.L., Robbins P.A. Effects of haloperidol on ventilation during isocapnic hypoxia in humans. J. Appl. Physiol. 1997, 83:1110-1115.
40. Peterson A., Gilman T.L., Banks M.L., Sprague J.E. Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Synapse 2006, 59:317-319.
41. Reddy M.K., Patel K.P., Schultz H.D. Differential role of the paraventricular nucleus of the hypothalamus in modulating the sympathoexcitatory component of peripheral and central chemoreflexes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R789-R797.
42. Resta O., Pannacciulli N., Di Guoia G., Stefano A., Barbaro M.P., De Pergola G. High prevalence of previously unknown subclincial hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr. Metab. Cardiovasc. Dis. 2004, 14:248-253.
43. Roos A., Links T., de Jong-van den Berg L.T.W., Gans R.O.B., Wolffenbuttel B.H.R., Bakker S.J.L. Thyroid peroxidase antibodies, levels of thyroid stimulating hormone and development of hypothyroidism in euthyroid subjects. Eur. J. Int. Med. 2010, 21:555-559.
44. Sakellaropoulou A.V., Hatzistilianou M.N., Emporiadou M.N., Aivazis V.T., Rousso I., Athanasiadou Piperopoulou F. Evaluation of thyroid gland function in children with obstructive apnea hypopnea syndrome. Int. J. Immunopathol. Pharmacol. 2011, 24:377-386.
45. Sarkar P.K., Durga N.D., Morris J.J., Martin J.V. In vitro thyroid hormone rapidly modulates protein phosphorylation in cerebrocortical synaptosomes from adult rat brain. Neuroscience 2006, 137:125-132.
46. Schlenker E., Barnes L., Hansen S., Martin D. Cardiorespiratory and metabolic responses to injection of bicuculline into the hypothalamic paraventricular nucleus (PVN) of conscious rats. Brain Res. 2001, 895:33-40.
47. Schlenker E.H. In hamsters dopamine D2 receptors affect ventilation during and following intermittent hypoxia. Comp. Biochem. Physiol. Part A: Mol. Int. Physiol. 2007, 148:674-680.
48. Schlenker E.H., Means R., Burbach J.A. Naloxone stimulates oxygen consumption but not ventilation in hypothyroid hamsters. Physiol. Behav. 1994, 56:635-638.
49. Schlenker E.H., Schultz H.D. Hypothyroidism attenuates SCH 23390-mediated depression of breathing and decreases D1 receptor expression in carotid bodies, PVN and striatum of hamsters. Brain Res. 2011, 1405:40-51.
50. Schwartz P.J., Erk S.D. Regulation of central dopamine-2 receptor sensitivity by a proportional control thermostat in humans. Psychiatry Res. 2004, 127:19-26.
51. Slotkin T.A., Slepetis R.J. Obligatory role of thyroid hormones in development of peripheral sympathetic and central nervous system catecholaminergic neurons: effects of propylthiouracil-induced hypothyroidism on transmitter levels, turnover and release. J. Pharm. Exp. Ther. 1984, 230:53-61.
52. Tews M., Shah S., Gossain V. Hypothyroidism: mimicker of common complaints. Emerg. Med. Clin. N. Am. 2005, 23:649-667. vii.
53. Varney A.A., Schlenker E.H. Thyroid status affects 5-HT2A receptor modulation of breathing before, during, and following exposure of hamsters to acute intermittent hypoxia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R2070-R2080.
54. Weiner D.M., Levey A.I., Sunahara R.K., Niznik H.B., O'Dowd B.F., Seeman P., Brann M.P. D1 and D2 dopamine receptor mRNA in rat brain. PNAS 1991, 88:1859-1863.
55. Wu T., Flowers J., Tudiver F., Wilson J., Punyasavatsut N. Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr. 2006, 6:12-18.
56. Xiao M.-F., Xu J.-C., Tereshchenko Y., Novak D., Schachner M., Kleene R. Neural cell adhesion molecule modulates dopaminergic signaling and behavior by regulating dopamine D2 receptor internalization. J. Neurosci. 2009, 29:14752-14763.
57. Xu T.-X., Yao W.-D. D1 and D2 dopamine receptors in separate circuits cooperate to drive associative long-term potentiation in the prefrontal cortex. PNAS 2010, 107:16366-16371.